Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors. Canning, P., Ruan, Q., Schwerd, T., Hrdinka, M., Maki, J. L., Saleh, D., Suebsuwong, C., Ray, S., Brennan, P. E., Cuny, G. D., Uhlig, H. H., Gyrd-Hansen, M., Degterev, A., & Bullock, A. N. CHEMISTRY & BIOLOGY, 22(9):1174-1184, SEP 17, 2015.
doi  bibtex   
@article{ WOS:000364012100003,
Author = {Canning, Peter and Ruan, Qui and Schwerd, Tobias and Hrdinka, Matous and
   Maki, Jenny L. and Saleh, Danish and Suebsuwong, Chalada and Ray, Soumya
   and Brennan, Paul E. and Cuny, Gregory D. and Uhlig, Holm H. and
   Gyrd-Hansen, Mads and Degterev, Alexei and Bullock, Alex N.},
Title = {Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant
   Type II Kinase Inhibitors},
Journal = {CHEMISTRY \& BIOLOGY},
Year = {2015},
Volume = {22},
Number = {9},
Pages = {1174-1184},
Month = {SEP 17},
DOI = {10.1016/j.chembiol.2015.07.017},
ISSN = {1074-5521},
EISSN = {1879-1301},
ResearcherID-Numbers = {Hrdinka, Matous/B-9187-2011
   },
ORCID-Numbers = {Brennan, Paul/0000-0002-8950-7646
   Suebsuwong, Chalada/0000-0001-9406-0386
   Canning, Peter/0000-0001-9678-4169
   Uhlig, Holm/0000-0002-6111-7355
   Gyrd-Hansen, Mads/0000-0001-5641-5019
   Cuny, Gregory/0000-0002-3188-4748
   Hrdinka, Matous/0000-0002-2981-2825},
Unique-ID = {WOS:000364012100003},
}

Downloads: 0